← Leaderboards
Richard Malley
Brigham And Women'S Hospital
$13,476,616
Attributed
$13,476,616
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,253,396 · 8
By mechanism
R01$12,062,318 · 4
U19$5,038,678 · 2
R56$649,120 · 1
K08$503,280 · 1
Top collaborators
- Jay K Kolls1 shared
- Gregory P Priebe1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Gerald B Pier$23,267,480
- Vijay K Kuchroo$71,617,613
- Laurie E Comstock$15,848,134
- Lawrence C Paoletti$4,276,990
- Gregory P Priebe$4,791,718
Others in their field
Top investigators on “Immunization”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmunizationImmunityStreptococcus PneumoniaeCellsSerotypingProteinsT-LymphocyteResponseAntigensAntibodiesPolysaccharidesBaseCd4 Positive T LymphocytesImmune ResponseMediatingVaccinesSuccessLaboratoriesConjugate VaccinesBacteriaChildCytokinePneumococcal InfectionsExtracellular
Grant awards (27)
Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity (IMPACT-CETR)$4,776,780
U19 · FY2025 · AI · contact PI
Administrative Core: Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity (IMPACT-CETR)$261,898
U19 · FY2025 · AI · contact PI
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine$1,144,476
R01 · FY2022 · AI · contact PI
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine$1,153,542
R01 · FY2021 · AI · contact PI
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine$1,067,677
R01 · FY2020 · AI · contact PI
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine$1,076,287
R01 · FY2019 · AI · contact PI
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine$1,439,101
R01 · FY2018 · AI · contact PI
Enhancing neonatal immunity to Streptococcus pneumoniae$396,500
R01 · FY2016 · AI · contact PI
Enhancing neonatal immunity to Streptococcus pneumoniae$396,500
R01 · FY2015 · AI · contact PI
S. pneumoniae pilus regulation and host response$649,120
R56 · FY2014 · AI · contact PI
Enhancing neonatal immunity to Streptococcus pneumoniae$496,442
R01 · FY2014 · AI · contact PI
Enhancing neonatal immunity to Streptococcus pneumoniae$372,710
R01 · FY2013 · AI · contact PI
Enhancing neonatal immunity to Streptococcus pneumoniae$415,000
R01 · FY2012 · AI · contact PI
Mechanisms of Immunity to Pneumococcal Colonization$406,225
R01 · FY2011 · AI · contact PI
Mechanisms of Immunity to Pneumococcal Colonization$410,329
R01 · FY2010 · AI · contact PI
Pneumococcal immunization through a novel mechanism$398,429
R01 · FY2010 · AI · contact PI
Mechanisms of Immunity to Pneumococcal Colonization$414,473
R01 · FY2009 · AI · contact PI
Pneumococcal immunization through a novel mechanism$402,453
R01 · FY2009 · AI · contact PI
Mechanisms of Immunity to Pneumococcal Colonization$414,473
R01 · FY2008 · AI · contact PI
Pneumococcal immunization through a novel mechanism$402,453
R01 · FY2008 · AI · contact PI
Mechanisms of Immunity to Pneumococcal Colonization$422,500
R01 · FY2007 · AI · contact PI
Pneumococcal immunization through a novel mechanism$410,248
R01 · FY2007 · AI · contact PI
Pneumococcal immunization through a novel mechanism$422,500
R01 · FY2006 · AI · contact PI
Pneumolysin, Innate and Acquired Immunity to Pneumococci$128,520
K08 · FY2005 · AI
Pneumolysin, Innate and Acquired Immunity to Pneumococci$128,520
K08 · FY2004 · AI
Pneumolysin, Innate and Acquired Immunity to Pneumococci$128,520
K08 · FY2003 · AI
Pneumolysin, Innate and Acquired Immunity to Pneumococci$117,720
K08 · FY2002 · AI